Trial intelligence / Profile preview

Therapeutic drug monitoring to optimize vancomycin level for pediatric patients

TCTR20180818003Recruiting

Sponsor
Ratchadaphiseksomphot Endowment Fund
Start
Jun 2018
Modality
Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of vancomycin in bacterial disease, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Jun 2018; status: recruiting.

02

Drugs

vancomycin
03

Conditions

bacterial disease

Beyond the preview

Go deeper on TCTR20180818003.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20180818003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call